CNS Pharmaceuticals Inc (CNSP) — Defensive Interval Ratio
CNS Pharmaceuticals Inc (CNSP) has a Defensive Interval Ratio of 0 days as of December 2025. Defensive assets of $0.00 (cash $-, short-term investments $-, receivables $0.00) cover 0 days of daily cash needs of $11.24K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
CNS Pharmaceuticals Inc Defensive Interval Ratio (2023–2025)
This chart shows how CNS Pharmaceuticals Inc's Defensive Interval Ratio has evolved across 3 annual periods from 2023 to 2025. As of December 2025, the ratio stands at 0 days, meaning defensive assets of $0.00 can fund 0 days of operations without new revenue. For the complete balance sheet picture, see CNS Pharmaceuticals Inc assets under control.
Annual Defensive Interval Ratio for CNS Pharmaceuticals Inc (2023–2025)
The table below presents the year-by-year Defensive Interval Ratio for CNS Pharmaceuticals Inc from 2023 to 2025, covering 3 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See CNSP net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 0 days | $0.00 | $11.24K/day | $- | $- | ▼ -128 days |
| 2024 | 128 days | $882.54K | $6.92K/day | $- | $- | ▲ +128 days |
| 2023 | 0 days | $0.00 | $16.80K/day | $- | $- | — |